Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ivabradine on Levcromakalim-Induced Migraine
NCT04853797Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- May 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine without aura comparing Levcromakalim - Ivabradine with Levcromakalim - Placebo (2 arms). Primary endpoint: Incidence of migraine attacks at 12 hours. Started May 2021; status: completed.
02
Drugs
ivabradine
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT04853797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853797.